Signum out-licenses SIG990 to Dermata to develop new topical treatment for

Signum out-licenses SIG990 to Dermata to develop new topical treatment for
US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat patients with rosacea, a chronic skin condition. SIG990 is claimed to …
Read more on Pharmaceutical Business Review

Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of
The Company expects to select a partner and secure a licensing agreement by the second quarter of 2015. The topical nanoparticle formulation of AmiKet will be developed collaboratively by Immune and Yissum upon the execution of a license agreement …
Read more on PR Newswire (press release)

Moberg Pharma Announces Grant of EU Patent for MOB-015 Related to Topical
Moberg Pharma AB (STO:MOB) today announced that the European Patent Office has issued Patent no. 2 672 962, relating to its topical treatment MOB-015 for onychomycosis (nail fungus). The patent is expected to be in effect until 2032. In September 2014 …
Read more on Business Wire (press release)

Posted in Flea Protection Media | Tagged , , , , , , , | Leave a comment

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>